https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-rss/?orgId=123688&title=Latest+News A selection of the latest research, academic, and other newsworthy developments at Medical Oncology and Hematology en-us Copyright 2026 Yale School of Medicine Sat, 16 May 2026 17:49:03 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/why-does-melanoma-spread-to-the-brain-a-yale-team-is-chasing-the-answer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/why-does-melanoma-spread-to-the-brain-a-yale-team-is-chasing-the-answer/ A team of Yale researchers believes the key to stopping melanoma from spreading to the brain lies in the brain's own immune system, not within the tumor. Thu, 14 May 2026 04:00:00 Z https://www.cancernetwork.com/view/clinical-context-mariposa-efficacy-in-1l-egfrm-nsclc https://www.cancernetwork.com/view/clinical-context-mariposa-efficacy-in-1l-egfrm-nsclc Dr. Sarah Goldberg from Yale University School of Medicine and Dr. Misako Nagasaka from UCI Health open a discussion on subcutaneous amivantamab every 4 weeks plus lazertinib as a first-line treatment for EGFR-mutated advanced non–small cell lung cancer (NSCLC). Tue, 12 May 2026 04:00:00 Z https://www.wtnh.com/news/health/may-is-melanoma-awareness-month/ https://www.wtnh.com/news/health/may-is-melanoma-awareness-month/ In today’s health headlines, a timely topic with the warm weather here and the sun getting stronger. May is Melanoma Awareness Month, raising awareness about the deadliest form of skin cancer. Mon, 11 May 2026 04:00:00 Z https://www.cancernetwork.com/view/novel-hp1k-inhibitor-shows-favorable-responses-in-ccrcc-solid-tumors https://www.cancernetwork.com/view/novel-hp1k-inhibitor-shows-favorable-responses-in-ccrcc-solid-tumors The HPK1 inhibitor NDI-101150 achieved “impressive” single-agent activity and a manageable safety profile as a monotherapy and in combination with pembrolizumab (Keytruda) among patients with advanced solid tumors, including clear cell renal cell carcinoma (ccRCC), in a phase 1/2 trial (NCT05128487) published in Cell Reports Medicine. Mon, 11 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/hope-healing-and-gratitude-a-life-reimagined-after-multiple-myeloma/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/hope-healing-and-gratitude-a-life-reimagined-after-multiple-myeloma/ Peter Otis shares his experience with multiple myeloma, and the healing power of gratitude and perspective. Mon, 11 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/calculating-cancer-risk-through-the-genetic-fingerprints-of-tumors/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/calculating-cancer-risk-through-the-genetic-fingerprints-of-tumors/ A new tool offers insights into understanding why every patient has a unique cancer journey. Fri, 08 May 2026 14:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/lajos-pusztai-md-dphil-named-a-giant-of-cancer-carer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/lajos-pusztai-md-dphil-named-a-giant-of-cancer-carer/ OncLive®, the nation’s leading multimedia resource for oncology professionals, is pleased to announce the winners of the 14th annual Giants of Cancer Care® awards. Fri, 08 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/novel-drug-shows-promise-for-treating-advanced-kidney-cancer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/novel-drug-shows-promise-for-treating-advanced-kidney-cancer/ A new immune therapy, which releases the immune system’s “brakes,” successfully treats a subset of patients with clear cell renal cell carcinoma. Thu, 07 May 2026 18:00:00 Z https://www.livefromstage4.org/episodes/front-row-seat-cure-eric-winer https://www.livefromstage4.org/episodes/front-row-seat-cure-eric-winer The conversation moves through the clinical landscape with rare clarity. Dr. Winer walks through three trials — CLEOPATRA, PATINA, and DESTINY-Breast09 — not as a dry literature review, but as building blocks of an evolving argument: that for some patients with HER2-positive metastatic breast cancer, long-term remission achieved through standard therapy isn't just possible. It's already happening. Tue, 05 May 2026 04:00:00 Z https://ashpublications.org/ashclinicalnews/news/9241/frontline-eltrombopag-plus-ist-demonstrates-cost https://ashpublications.org/ashclinicalnews/news/9241/frontline-eltrombopag-plus-ist-demonstrates-cost Frontline treatment with the oral thrombopoietin-receptor agonist eltrombopag plus immunosuppressive therapy (IST) was confirmed as efficacious compared with IST alone for newly diagnosed severe aplastic anemia in both the European 2022 phase III RACE trial and a 2018 NIH phase I-II trial.1,2 However, adoption of this standard of care is constrained by its high cost — approximately $157,000 for a six-month course in the U.S. Tue, 05 May 2026 04:00:00 Z https://www.wfsb.com/video/2026/05/04/melanoma-monday-skin-cancer-awareness/ https://www.wfsb.com/video/2026/05/04/melanoma-monday-skin-cancer-awareness/ Melanoma Monday: Skin cancer awareness with Dr. Harriet Kluger Mon, 04 May 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/119-yale-cancer-physicians-named-to-2026-top-doctors-list/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/119-yale-cancer-physicians-named-to-2026-top-doctors-list/ List of 119 Yale Cancer Center physicians named as 2026 'Top Doctors' Fri, 01 May 2026 09:05:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/type-of-fat-not-the-amount-fuels-pancreatic-cancer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/type-of-fat-not-the-amount-fuels-pancreatic-cancer/ A new study identifies oleic acid as an unexpected driver of tumor growth and points to omega-3-rich diets as a potential prevention strategy. Wed, 29 Apr 2026 14:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/zaidi-awarded-trailblazer-cancer-research-grant/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/zaidi-awarded-trailblazer-cancer-research-grant/ Samir Zaidi, MD, PhD, was awarded an American Association for Cancer Research (AACR) Trailblazer Cancer Research Grant during the opening ceremony of the AACR annual meeting. Wed, 29 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/internal-medicine-radiology-pathology-residents-hold-2nd-clinicopathologic-conference/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/internal-medicine-radiology-pathology-residents-hold-2nd-clinicopathologic-conference/ Residents from the Departments of Internal Medicine, Radiology and Biomedical Imaging, and Pathology hold their second Clinicopathologic Conference. Fri, 24 Apr 2026 04:00:00 Z https://www.medpagetoday.com/reading-room/asco/gastric-cancer/120921 https://www.medpagetoday.com/reading-room/asco/gastric-cancer/120921 Study calculated specific economic and societal benefits over 3 and 5 years Fri, 24 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/new-research-presented-from-yale-cancer-center-at-the-aacr-annual-meeting/ Yale Cancer Center faculty and trainees joined over 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in San Diego for the 117th American Association for Cancer Research (AACR) annual meeting. Thu, 23 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/david-rimm-md-phd-chosen-for-pathology-cancer-research-award/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/david-rimm-md-phd-chosen-for-pathology-cancer-research-award/ The American Association for Cancer Researcher (AACR) named David Rimm, MD, PhD, Anthony N. Brady Professor of Pathology and of Medicine (Medical Oncology), as recipient of the 2026 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research. Fri, 10 Apr 2026 14:15:00 Z https://www.everydayhealth.com/cancer/metastatic-kidney-cancer-survival-rates/ https://www.everydayhealth.com/cancer/metastatic-kidney-cancer-survival-rates/ Other health issues may affect survival by changing what treatments you can have, says David Braun, MD, PhD, a medical oncologist and physician scientist at Yale Cancer Center in Connecticut. Fri, 10 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/dr-sarah-schellhorn-named-fellow-of-the-american-society-of-clinical-oncology/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/dr-sarah-schellhorn-named-fellow-of-the-american-society-of-clinical-oncology/ Sarah Schellhorn, MD, associate professor of medicine (medical oncology and hematology) and chief of Ambulatory Services at Smilow Cancer Hospital, has been named a Fellow of the American Society of Clinical Oncology (FASCO). Thu, 09 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/lung-cancer-development-treatment-and-what-comes-next/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/lung-cancer-development-treatment-and-what-comes-next/ Why do some lung cancers stop responding to drugs that once worked? And why does the immune system sometimes fail to recognize and destroy tumors? Pathologist Katerina Politi, PhD, has spent more than two decades pursuing those questions, and her team at Yale School of Medicine is now closer to finding answers that could reshape how patients are treated. Wed, 08 Apr 2026 18:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/center-for-thoracic-cancers-hosts-celebrate-the-unexpected/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/center-for-thoracic-cancers-hosts-celebrate-the-unexpected/ On Tuesday, April 7, 2026, the Center for Thoracic Cancers hosted a special event for patients and caregivers, with Annabelle Gurwitch. Wed, 08 Apr 2026 04:00:00 Z https://video.vegaspbs.org/video/the-alarming-rise-of-cancer-and-steps-to-lower-the-risk-fgw9is/ https://video.vegaspbs.org/video/the-alarming-rise-of-cancer-and-steps-to-lower-the-risk-fgw9is/ Many think of cancer as a disease that mainly affects older people, but an increasing number of diagnoses are happening amongst the young. What is behind this alarming rise? And can anything be done to prevent it? Horizons moderator William Brangham explores those questions with experts, including Dr. Veda Giri, the director of Yale Cancer Center's early onset cancer program. Tue, 07 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/new-tool-offers-personalized-approach-to-blood-cancer-care/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/new-tool-offers-personalized-approach-to-blood-cancer-care/ A novel machine learning tool uses genetic data to determine if and when patients should undergo stem cell transplant for a rare blood cancer. Mon, 06 Apr 2026 19:00:00 Z https://www.everydayhealth.com/cancer/care-options-for-metastatic-and-recurrent-renal-cell-carcinoma/ https://www.everydayhealth.com/cancer/care-options-for-metastatic-and-recurrent-renal-cell-carcinoma/ These medications most often treat advanced kidney cancers such as RCC, often in combination with immunotherapy. Targeted therapies work best for short-term needs, but they may not work as well long-term, says David Braun, MD, PhD, a medical oncologist and physician scientist at Yale Cancer Center in New Haven, Connecticut. Fri, 03 Apr 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-cancer-center-hosts-the-paul-calabresi-md-memorial-lecture/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-cancer-center-hosts-the-paul-calabresi-md-memorial-lecture/ On Tuesday, March 31, 2026, Dr. Robert A. Winn, Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center, and Professor of Pulmonary Disease and Critical Care Medicine at VCU School of Medicine presented the Paul Calabresi, MD, Memorial Lectureship, hosted by Roy Herbst, MD, PhD. A dinner was held in his honor, along with a ceremony in the Calabresi Conference Room at Yale Cancer Center. Yale Medical Oncology-Hematology Fellows also had a chance to speak with Dr. Winn following his talk. Wed, 01 Apr 2026 04:00:00 Z https://www.cancernetwork.com/view/berzosertib-combo-displays-safety-and-tolerability-in-head-and-neck-cancer https://www.cancernetwork.com/view/berzosertib-combo-displays-safety-and-tolerability-in-head-and-neck-cancer “[I]t will be prudent to monitor for increased toxicity, particularly hematologic, should this or a similar regimen move into larger studies with less restrictive eligibility especially in [patients with] HNSCC who are more likely to present with multiple comorbid conditions which predispose to increased risk of adverse outcomes,” lead investigator Aarti Bhatia, MD, MPH, associate professor of Medicine (Medical Oncology) and clinical research team leader of the Head and Neck Cancers Program at the Yale School of Medicine, wrote with study coinvestigators in the manuscript. Fri, 27 Mar 2026 04:00:00 Z https://www.nbcconnecticut.com/video/news/local/how-diet-can-impact-your-risks-of-colorectal-cancer/3717696/ https://www.nbcconnecticut.com/video/news/local/how-diet-can-impact-your-risks-of-colorectal-cancer/3717696/ Medical experts are seeing more patients under 50 years old be diagnosed with colorectal cancer. Dr. Jeremy Kortmansky, clinical director of the GI Medical Oncology Division at Yale Cancer Center, spoke with NBC Connecticut about how diet and other lifestyle factors impact colorectal cancer risk. Wed, 25 Mar 2026 04:00:00 Z https://www.ctinsider.com/business/article/car-t-cell-therapy-ct-uconn-yale-22087550.php https://www.ctinsider.com/business/article/car-t-cell-therapy-ct-uconn-yale-22087550.php Getting old goes much deeper than wrinkles and gray hair — many of the cells in your body are literally wearing out due to age. So what if your own immune system could be harnessed to sweep out aging cells and restore youth from the inside out? That’s one potential use of a class of gene therapies that are quickly moving from research labs at Jackson Laboratory in Farmington and clinical trials at Yale University to doctor’s offices across the state. Tue, 24 Mar 2026 13:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/ai-in-cancer-workshop-advancing-precision-medicine-through-interdisciplinary-innovation/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/ai-in-cancer-workshop-advancing-precision-medicine-through-interdisciplinary-innovation/ On Friday, March 20th, the Precision Medicine in Cancer Program at Yale Cancer Center hosted a day long workshop focused on real-world applications of AI across the cancer care continuum, from bench to clinical implementation to population health. Tue, 24 Mar 2026 04:00:00 Z https://www.medscape.com/viewarticle/can-romiplostim-reduce-chemotherapy-disruptions-gi-cancer-2026a10008hr https://www.medscape.com/viewarticle/can-romiplostim-reduce-chemotherapy-disruptions-gi-cancer-2026a10008hr “These sweeping results usher in a potentially transformative era of growth factor treatment for [chemotherapy-induced thrombocytopenia], providing a strong rationale for the use of romiplostim in chemotherapy for solid tumors when the risk of [chemotherapy-induced thrombocytopenia] is predicted to be high,” wrote authors of an accompanying editorial, George Goshua, MD, SM, and Alfred Ian Lee, MD, PhD, Yale School of Medicine, New Haven, Connecticut. Thu, 19 Mar 2026 04:00:00 Z https://www.cancernetwork.com/view/which-novel-drug-classes-hold-promise-in-multiple-myeloma-therapy- https://www.cancernetwork.com/view/which-novel-drug-classes-hold-promise-in-multiple-myeloma-therapy- In a conversation with CancerNetwork®, Natalia Neparidze, MD, research leader of the myeloma program at Yale Cancer Center, highlighted various drug and treatment classes that may impact the multiple myeloma paradigm. Beyond CAR T-cell therapies and bispecific antibodies, she detailed the cereblon E3 ligase modulator (CELMoD) agents and trispecific antibodies that represent “exciting opportunities” in the space. Tue, 17 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/connecticut-academy-of-science-and-engineering-elects-eight-from-ysm/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/connecticut-academy-of-science-and-engineering-elects-eight-from-ysm/ Eight Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering. Fri, 13 Mar 2026 14:00:00 Z https://www.wtnh.com/news/health/doctors-seeing-rise-in-colorectal-cancer-cases-in-younger-adults/ https://www.wtnh.com/news/health/doctors-seeing-rise-in-colorectal-cancer-cases-in-younger-adults/ Historically, colorectal cancer has been considered a disease that affects older adults, but doctors are now seeing a troubling shift, as researchers continue to look for answers to why colorectal cancer is affecting younger people. Dr. Veda Giri, director of the early onset cancer program at Yale Cancer Center and Smilow Cancer Hospital, joined WTNH's Good Morning Connecticut at 9 a.m. to discuss. Fri, 13 Mar 2026 04:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/hormone-behind-obesity-induced-pancreatic-cancer/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/hormone-behind-obesity-induced-pancreatic-cancer/ Yale scientists identified a hormone that initiates the development and progression of pancreatic cancer in obesity. And it’s not insulin. Thu, 12 Mar 2026 19:00:00 Z https://www.youtube.com/watch?v=bA6eCX5_gEE https://www.youtube.com/watch?v=bA6eCX5_gEE Veda Giri, MD, recently joined the Connecticut East This Week podcast to discuss the rise of colorectal cancer in adults under 50 and why this trend is becoming an increasing concern for younger people. Fri, 06 Mar 2026 18:00:00 Z https://www.nbcconnecticut.com/video/news/local/kidney-cancer-awareness-month-shines-spotlight-on-one-of-the-most-common-cancers-in-the-country/3710945/ https://www.nbcconnecticut.com/video/news/local/kidney-cancer-awareness-month-shines-spotlight-on-one-of-the-most-common-cancers-in-the-country/3710945/ March is kidney cancer awareness month. Dr. Michael Hurwitz with Yale Cancer Center and Smilow Cancer Hospital spoke with NBC Connecticut, answering commonly asked questions about kidney cancer. Fri, 06 Mar 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/metavivor-award-to-support-kahns-research-on-brain-metastases/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/metavivor-award-to-support-kahns-research-on-brain-metastases/ Adriana Kahn, MD, assistant professor of medicine (medical oncology), received an Early Career Investigator Award from METAvivor, a nonprofit group exclusively devoted to metastatic cancer research. Wed, 04 Mar 2026 05:00:00 Z https://www.wtnh.com/news/health/future-looks-promising-for-cancer-detecting-blood-tests/ https://www.wtnh.com/news/health/future-looks-promising-for-cancer-detecting-blood-tests/ Dr. Eric Winer, the director of the Yale Cancer Center, explained that one way blood cancer tests, or so-called liquid biopsies, are used is to monitor cancer patients. “Somebody has had treatment for cancer, and we’re trying to predict their risk of having a recurrence of cancer,” Winer said. Mon, 02 Mar 2026 05:00:00 Z https://www.healthcentral.com/news/breast-cancer/new-tool-for-chemo-resistant-cancers-cholesterol-drug https://www.healthcentral.com/news/breast-cancer/new-tool-for-chemo-resistant-cancers-cholesterol-drug Research reveals how a standard medication for lowering cholesterol could play a part in treatment for triple-negative breast cancer. “Based on the mechanism of pitavastatin, the effect on TNBC has biological plausibility,” Dr. Lustberg says. Mon, 02 Mar 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/surgery-receives-gift-breast-cancer-research-reconstruction/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/surgery-receives-gift-breast-cancer-research-reconstruction/ The gift will fund vital initiatives at YSM, focusing on advancing clinical care, research, and education in breast cancer treatment and reconstruction. Thu, 19 Feb 2026 14:00:00 Z https://www.bloodcancerstoday.com/post/novel-momelotinib-combinations-in-myelofibrosis https://www.bloodcancerstoday.com/post/novel-momelotinib-combinations-in-myelofibrosis An expert roundtable moderated by Nikolai Podoltsev, MD, PhD, of Yale Cancer Center explores momelotinib combined with nuvisertib or luspatercept for the treatment of myelofibrosis. Thu, 19 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/dr-xiao-wang-joins-center-for-gastrointestinal-cancers-at-smilow-cancer-hospital-and-yale-cancer-center/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/dr-xiao-wang-joins-center-for-gastrointestinal-cancers-at-smilow-cancer-hospital-and-yale-cancer-center/ Dr. Xiao Wang is a Yale medical oncologist that cares for patients with gastrointestinal malignancies as part of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital in North Haven. Mon, 16 Feb 2026 05:00:00 Z https://www.wsj.com/health/wellness/hodgkins-lymphoma-persistent-itch-cancer-symptoms-women-3aa14607? https://www.wsj.com/health/wellness/hodgkins-lymphoma-persistent-itch-cancer-symptoms-women-3aa14607? Two years, 11 doctors and one diagnosis later, I’ve learned a lot about how medicine can miss women’s symptoms. Wall Street Journal reporter Jessica Toonkel shares her story and interviews experts along the way, including Hematologist Kelsey Martin, MD. Dr. Martin is a Women's Health Research at Yale Collaborative Member. Fri, 13 Feb 2026 05:00:00 Z https://connecticut.news12.com/yale-medical-oncologist-says-colorectal-cancer-can-be-detected-with-different-types-of-screenings https://connecticut.news12.com/yale-medical-oncologist-says-colorectal-cancer-can-be-detected-with-different-types-of-screenings "Colorectal cancer can affect patients in many different ways. So, sometimes it's completely asymptomatic, and it's identified on a colonoscopy," said medical oncologist Dr. Michael Cecchini, the co-director for the colorectal program for the Center of Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center. Thu, 12 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-cancer-answers-cited-as-a-top-connecticut-medical-podcast/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-cancer-answers-cited-as-a-top-connecticut-medical-podcast/ “Yale Cancer Answers” has been named as one of the 15 best Connecticut Medical Podcasts by FeedSpot Podcasts. Wed, 11 Feb 2026 05:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-study-identifies-a-new-class-of-drug-targets-for-aggressive-leukemia/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-study-identifies-a-new-class-of-drug-targets-for-aggressive-leukemia/ Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer’s survival. If one component of the complex is deleted or removed, the cancer cells are sent into overdrive and die, finds a Yale-led study published Feb.10 in Science Signaling. Tue, 10 Feb 2026 19:00:00 Z https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-cancer-centers-crtec-hosts-cancer-research-discovery-program/ https://websites4-live-prod.ysmdevs.com/internal-medicine/oncology-hematology/news-article/yale-cancer-centers-crtec-hosts-cancer-research-discovery-program/ On February 6, 2026, YCC CRTEC welcomed students from Hill Regional Career High School to our Cancer Research Discovery Program (CRDP), a day designed to introduce them to careers in cancer research and medicine. Tue, 10 Feb 2026 05:00:00 Z https://www.medscape.com/viewarticle/risk-based-breast-cancer-screening-nears-turning-point-2026a10003tc?form=fpf https://www.medscape.com/viewarticle/risk-based-breast-cancer-screening-nears-turning-point-2026a10003tc?form=fpf Eric Winer, MD, director of the Yale Cancer Center in New Haven, Connecticut, called the study “the most important thing we’ve heard at this conference.” Fri, 06 Feb 2026 05:00:00 Z https://www.statnews.com/2026/02/02/cancer-immunotherapy-morning-infusions-most-effective-study-says/ https://www.statnews.com/2026/02/02/cancer-immunotherapy-morning-infusions-most-effective-study-says/ While the study is a signal that time of day for immunotherapy infusion is worth investigating further, Roy Herbst, the deputy director of the Yale Cancer Center, said he’s not going to change practice based on the trial. “It’s intriguing. This is maybe a wake-up call to look at it more," Herbst said. Mon, 02 Feb 2026 05:00:00 Z